This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
More empowered buyers has resulted in longer sales cycles. And, 50-90% of the journey is complete before a buyer interacts with a sales rep. This shift in behavior should be taken seriously by any sales team, whether inside or out in the field. Here is a list of 130 sales statistics broken out across 20 categories.
Boston is emerging as one of the hottest startup cities in the country, which is great news for sales professionals. These companies are all backed by venture capital and are currently hiring in sales roles. This is by no means an exhaustive list, but here are some great companies to consider for your next sales job. ProfitWell.
I have been fortunate to work with developing reps, generating sales, and making connections with surgeons. Was it med sales from the beginning? Was it med sales when you were a younger man and you said, “I always want to do that?” What medical sales stuff did you do before you started the schooling and the teaching that you do?
Rituxan received its first FDA approval in 1997 for the treatment of B-cell non-Hodgkin’s lymphoma (B-NHL) and reached peak global sales of $7.5bn in 2014. Globally, the first rituximab biosimilar, Dr Reddy’s Laboratories’ Reditux, was approved in India in 2007. Rituxan’s success made it a prime target for biosimilar developers.
Medical sales reps hardly have any time for themselves or their families. But with a new software tool, sales reps are now going to have more than enough time. He spent his career in aesthetics device sales. It’s one of the highest earning industries and the most competitive. You are going to have to read this.
If you’re looking to get into a career in medical sales, this is the episode for you. That’s not only a big deal in the medical sales space. He is also the youngest sales director in Johnson & Johnson’s Vision Care. We get into what makes an amazing sales rep. That’s a big deal in the corporate world. I’m doing well.
Lucentis was first approved in the US in 2007 for wet AMD and grew quickly thereafter as additional indications were approved. billion in sales from it in 2021, while Novartis made $2.2 billion from sales in Europe – where Byooviz made its debut last year – and the rest of the world. .”
What happens when MMA, telecom, medical sales, and marketing meet together? Chandler has a strong background in sales, marketing, and territory management. Evan comes from the telecommunication industry, but is equipped in sales strategy and customer targeting. They go by the names of Chandler and Evan. Evan, how about you?
The substance patent expired in 2007. ” “Given the importance of this issue to patients, payors (including the federal government), and prescription-drug competition, this court should grant review,” it adds. The post Teva asks SCOTUS to overturn “skinny label” verdict on GSK drug appeared first on.
Prior to becoming President of Global Human Health, he served as President of Merck’s global pharmaceutical business from 2007 to 2010. focused leadership roles spanning sales, marketing, and managed markets, as well as business and product development. His extensive experience at Merck also included global and U.S.-focused
It has boosted anti-tumour research by 60% since 2005, at a cost of $1.6bn, in the hope of increasing the share of company sales attributed to cancer drugs from the current level of 5% “There are a lot of patients that are suffering,” said Pfizer chief executive Jeffrey Kindler. So what’s driving the growth?
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content